AM-8508 is an orally bioactive PI3Kδ inhibitor with an IC 50 of 0.016 μM. AM-8508 selectively inhibits PI3Kδ , thereby blocking AKT phosphorylation mediated by the B cell receptor . AM-8508 suppresses the formation of antigen-specific IgG and IgM in rats immunized with keyhole limpet hemocyanin. AM-8508 can be used for the research of inflammatory diseases.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > PI3K | Products > Signaling Pathways > Akt
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。